Solventum vs Veeva Systems
Solventum (SOLV) and Veeva Systems (VEEV) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $14.3B
- Last close
- $84.50
- 12 months
- +6.3%
- Market value
- $50.7B
- Last close
- $266.22
- 12 months
- −1.6%
At a glance
- The biggest part of Solventum's revenue is Cost of product (76%); at Veeva Systems it is R&D and Quality Solutions (45%).
- By market value, Veeva Systems ($50.7B) is about 3.5 times Solventum ($14.3B).
- Over the last 12 months Solventum's share price moved +6.3% and Veeva Systems's −1.6%; against the S&P 500 that is +0.6 points and −7.3 points.
- In their last fiscal years Solventum kept 18.7% of revenue as net income and Veeva Systems 28.4%.
- In the last 90 days insiders reported 0 open-market purchases at Solventum and 0 at Veeva Systems; members of Congress disclosed 0 trades in Solventum and 0 in Veeva Systems.
- Next results: Solventum Feb 24, 2027, Veeva Systems Dec 3, 2026.
How each one makes money: Solventum revenue · Veeva Systems revenue
Share prices on one chart
Solventum and Veeva Systems, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Solventum SOLVNYSE · Health Care Technology | Veeva Systems VEEVNYSE · Health Care Technology | |
|---|---|---|
| Size and profitability | ||
| Market value | $14.3B | $50.7B |
| Revenue, last fiscal year | $8.32B | $3.2B |
| Net income, last fiscal year | $1.56B | $909M |
| Net marginNet income as a share of revenue | 18.7% | 28.4% |
| Free cash flow | −$10M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Common questions
How is Solventum different from Veeva Systems?
Solventum (SOLV) is in Health Care Technology on NYSE, with $8.32B of revenue in its last fiscal year and a net margin of 18.7%. Veeva Systems (VEEV) is in Health Care Technology on NYSE, with $3.2B of revenue in its last fiscal year and a net margin of 28.4%. The biggest part of Solventum's revenue is Cost of product (76%); at Veeva Systems it is R&D and Quality Solutions (45%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Solventum and Veeva Systems compare in size?
Veeva Systems has the larger market value: Solventum $14.3B and Veeva Systems $50.7B, at the last close.
Whose share price rose more over the last 12 months, SOLV or VEEV?
Over the last 12 months Solventum moved +6.3% and Veeva Systems −1.6%. Past price moves say nothing about the future.
Which has had more insider buying, Solventum or Veeva Systems?
Since 2006, Solventum insiders reported 1 open-market purchases against 0 for Veeva Systems. These are counts of what was filed, not a view on either stock.
Do members of Congress trade SOLV or VEEV?
In the last 12 months, members of Congress disclosed 3 trades in Solventum (SOLV) and 0 in Veeva Systems (VEEV).
When did insiders last buy SOLV and VEEV?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Solventum pageVeeva Systems pageRare insider trades this weekAll comparisons
https://oqro.io/compare/solv-vs-veev

